<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>CDC20 contributes to the development of human cutaneous squamous cell carcinoma through the Wnt/β‑catenin signaling pathway.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="CDC20 contributes to the development of human cutaneous squamous cell carcinoma through the Wnt/β‑catenin signaling pathway." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438437/bin/IJO-54-05-1534-g01.jpg"/> </div> <div class="text-side"> <h1>CDC20 contributes to the development of human cutaneous squamous cell carcinoma through the Wnt/β‑catenin signaling pathway.</h1> <p>Expression of CDC20 is associated with cSCC progression. (A) Normal skin (n=32) (magnification, ×100). (B) Actinic keratosis (n=31) (magnification, ×100). (C) cSCC in situ (Bowen's disease; n=27) (magnification, ×100). (D) Well-differentiated cSCC (n=29) (magnification, ×100). (E) Moderately or poorly differentiated cSCC (n=25) (magnification, ×100). (F) Semiquantitative analysis of CDC20 expression in the different tissues. CDC20, cell division cycle 20; cSCC, cutaneous squamous cell carcinoma; wd, well-differentiated; md/pd, moderately or poorly differentiated. *P&lt;0.05, ***P&lt;0.001 vs. normal skin.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30816486/" target="_blank">30816486</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>